[New European approval: Relatlimab/nivolumab in first -line treatment of advanced metastatic melanoma with less than 1% tumor expression of PD-L1].
作者信息
Boileau Marie, Boussemart Lise
机构信息
CHU de Lille, service de dermatologie, 59000 Lille, France; Univ Lille, 59000, Lille, France.
Nantes Université, Univ Angers, CHU Nantes, INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, 44000 Nantes, France.
出版信息
Bull Cancer. 2022 Dec;109(12):1230-1231. doi: 10.1016/j.bulcan.2022.09.008. Epub 2022 Oct 20.
PMID:36272842
Abstract
摘要
Zotero 插件